PIAS Antibodies

Santa Cruz Biotechnology delivers a wide array of PIAS monoclonal antibodies for advanced research in cellular signaling and gene regulation. PIAS monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PIAS proteins, or Protein Inhibitors of Activated STAT, are key regulators of signal transducer and activator of transcription (STAT) signaling pathways, which mediate cellular responses to cytokines and growth factors. Through modulation of STAT proteins, PIAS proteins influence immune response, cell growth, and differentiation, playing important roles in normal physiology and disease states, including cancer and autoimmune disorders. PIAS proteins participate in various cellular mechanisms beyond STAT regulation, including transcriptional control and protein modification. Understanding PIAS protein function has significant implications for developing targeted therapies in multiple disease contexts. Research involving PIAS proteins continues to reveal new insights into cellular regulation and disease mechanisms. PIAS monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of cellular processes and potential therapeutic applications.